Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Jelinek

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Antisense & Nucleic Acid Drug Development|February 6, 2003
The effectiveness of double-stranded short inhibitory RNAs (siRNAs) may depend on the method of transfectionD K Walters, D F Jelinek
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1987
Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1D F Jelinek, P E Lipsky
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
Phosphatidylinositol 3-kinase activation in normal human B lymphocytesK M Aagaard-Tillery, D F Jelinek
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1995
Differential activation of a calcium-dependent endonuclease in human B lymphocytes. Role in ionomycin-induced apoptosisK M Aagaard-Tillery, D F Jelinek
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
A role for phosphatidylinositol 3-kinase in generating T cell help for B cell growth and differentiationK M Aagaard-Tillery, D F Jelinek
Cellular Immunology|July 1, 1994
Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycinK M Aagaard-Tillery, D F Jelinek
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3S Hirohata, D F Jelinek, P E Lipsky
Journal of Clinical Microbiology|May 1, 1981
Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodiesD B Budzko, D F Jelinek, B W Wilcke
Blood|June 15, 1995
Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell linesJ J Westendorf, J M Lammert, D F Jelinek
Leukemia|June 1, 2002
Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approachJ D French, R C Tschumper, D F Jelinek
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Antisense & Nucleic Acid Drug Development|February 6, 2003
The effectiveness of double-stranded short inhibitory RNAs (siRNAs) may depend on the method of transfectionD K Walters, D F Jelinek
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1987
Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1D F Jelinek, P E Lipsky
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
Phosphatidylinositol 3-kinase activation in normal human B lymphocytesK M Aagaard-Tillery, D F Jelinek
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1995
Differential activation of a calcium-dependent endonuclease in human B lymphocytes. Role in ionomycin-induced apoptosisK M Aagaard-Tillery, D F Jelinek
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
A role for phosphatidylinositol 3-kinase in generating T cell help for B cell growth and differentiationK M Aagaard-Tillery, D F Jelinek
Cellular Immunology|July 1, 1994
Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycinK M Aagaard-Tillery, D F Jelinek
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3S Hirohata, D F Jelinek, P E Lipsky
Journal of Clinical Microbiology|May 1, 1981
Nonspecific reactions in the hemagglutination inhibition test for detection of rubella antibodiesD B Budzko, D F Jelinek, B W Wilcke
Blood|June 15, 1995
Expression and function of Fas (APO-1/CD95) in patient myeloma cells and myeloma cell linesJ J Westendorf, J M Lammert, D F Jelinek
Leukemia|June 1, 2002
Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approachJ D French, R C Tschumper, D F Jelinek
Pageof 6